Preparation and uses of reactive oxygen species scavenger derivatives
AssigneeXw Laboratories Inc.
InventorsJia-Ning Xiang, Zude Qi, Dezheng Ning, Xianbo Liu
Life of this patent
Estimating the term…
Abstract
Compounds of Formula (I)a or (I)b: including certain quinone derivatives, and the corresponding pharmaceutical compositions, which may serve to modulate ferroptosis in a subject. Also disclosed herein are the preparations of these compounds and pharmaceutical compositions and their potential uses in the manufacture of a medicament in reducing reactive oxygen species (ROS) in a cell and for preventing, treating, ameliorating certain related disorder or a disease.
Claims14
A compound of Formula (I)a or Formula (I)b, a pharmaceutically acceptable salts thereof, and individual enantiomers or diastereomers thereof:
- wherein,
- z is 0 or 1;
- L is absent;
- or L is selected from C1-C10 alkyl, C1-C10 alkoxyl, C3-7 cycloalkyl, C1-C10 alkylcycloalkyl, heterocycloalkyl, C1-C10 alkylheterocycloalkyl, C5-10 aryl, C1-C10 alkylaryl, C5-10 heteroaryl, and C1-C10 alkylheteroaryl;
- Q is selected from:
- wherein,
- n is an integer selected from 0 to 10;
- each of R1 and R2 is independently selected from hydrogen and CH3;
- each of R3 and R4 is independently selected from hydrogen and C1-C5 alkyl;
- each W is independently absent or is selected from O and S;
- and
- i) when W is absent, then R3 and R4, optionally, together form the following structure:
- ii) when W is O, then OR3 and OR4 optionally, together form the following structure:
- PEP is a peptidyl moiety having the following structure:
- wherein,
- each asterisk (*) independently denotes a chiral center in either an (S) or (R) configuration;
- m is an integer selected from 0 to 10;
- X1 is selected from hydrogen, —C(═O)—ORm, —S(O)—O—Rm, —S(O2)—O—Rm, —S(O2)—N—(Rm)2 and —C(═O)—N—(Rm)2, where Rm is C1-C6 alkyl, C1-C6 alkoxyl, C1-C6 alkenyl, C1-C6 haloalkyl, C3-C7 cycloalkyl, C1-C6 alkylcycloalkyl, C3-C7 heterocycloalkyl, C1-C6 alkylheterocycloalkyl, C5-C10 aryl, C1-C6 alkylaryl, C5-C10 heteroaryl, and C1-C6 alkylheteroaryl;
- each of X2, X3 and X4 is independently selected from C1-C10 alkyl, C1-C10 alkenyl, C5-C6 aryl, C1-C6 alkylaryl, heteroaryl, and C1-C6 alkylheteroaryl;
- A is absent, or A is selected from Ala, Leu, Ile, Phe, Met, Pro, Gly, Ser, Thr, Cys, Tyr, Asn, Gln, His, Lys, Arg, Asp, Glu, and Val, each of which can be in either a D or L configuration;
- wherein the amino residue is either unprotected, or protected by a protecting group selected from Cbz and Fmoc;
- and
- G is absent, or G is selected from —O—, —S—, —NH—, —NH—C(═O)—O—, —O—C(═O)—NH—, —NH—C(═O)—NH—, —NHSO2—, —SO—, —SO2—, and —NHC(═O)—.
Dependencies are inferred from the claim text.